Home/Filings/4/0001437749-25-029104
4//SEC Filing

UECKER DARRIN 4

Accession 0001437749-25-029104

CIK 0001625101other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 9:09 PM ET

Size

19.3 KB

Accession

0001437749-25-029104

Insider Transaction Report

Form 4
Period: 2025-09-11
UECKER DARRIN
DirectorChief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-09-11$4.00/sh+25,000$100,000147,872 total
  • Sale

    Common Stock

    2025-09-12$14.32/sh25,000$358,000122,872 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-09-1225,000131,534 total
    Exercise: $4.00From: 2019-09-08Exp: 2025-09-20Common Stock (25,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-12$4.00/sh+25,000$100,000147,872 total
  • Sale

    Common Stock

    2025-09-15$15.77/sh25,000$394,250122,872 total
  • Sale

    Common Stock

    2025-09-11$14.78/sh25,000$369,500122,872 total
  • Exercise/Conversion

    Common Stock

    2025-09-15$4.00/sh+25,000$100,000147,872 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-09-1125,000156,534 total
    Exercise: $4.00From: 2019-09-08Exp: 2025-09-20Common Stock (25,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-09-1525,000106,534 total
    Exercise: $4.00From: 2019-09-08Exp: 2025-09-20Common Stock (25,000 underlying)
Footnotes (5)
  • [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025.
  • [F2]The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $14.41 to $15.14 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
  • [F3]The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $13.80 to $14.76 per share.
  • [F4]The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.18 to $17.20 per share.
  • [F5]Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015.

Issuer

PULSE BIOSCIENCES, INC.

CIK 0001625101

Entity typeother

Related Parties

1
  • filerCIK 0001276311

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 9:09 PM ET
Size
19.3 KB